Partner Headlines - ICPT

  1. Morning Market Losers

    Benzinga
  2. Benzinga's Top #PreMarket Losers

    Benzinga
  3. CNBC's Stock Pops & Drops From August 12

    Benzinga
  4. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  5. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  6. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  7. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  8. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  9. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  10. Benzinga's Volume Movers

    Benzinga
  11. Morning Market Movers

    Benzinga
  12. Conatus Shares Move Higher On Industry Data

    Benzinga
  13. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  16. INTERCEPT PHARMACEUTICALS

    IBD
  17. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  18. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  19. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  20. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  21. Benzinga's Top Initiations

    Benzinga
  22. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  23. Top Healthcare Movers For June 9, 2014

    Benzinga
  24. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  25. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  26. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  27. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  28. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  29. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  30. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  31. Top Trending Tickers On StockTwits For March 17

    Benzinga
  32. Benzinga's Top #PreMarket Losers

    Benzinga
  33. Morning Gainers for Friday, March 14, 2014

    Benzinga
  34. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  35. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
  36. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  37. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  38. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  39. Mid-Morning Market Update: Markets Rise; Bank of America Profit ...

    Benzinga
  40. Benzinga's Top #PreMarket Gainers

    Benzinga
  41. Market Wrap For January 14: Markets Rebound On Earnings Season ...

    Benzinga
  42. Mid-Afternoon Market Update: Markets Continue Rally as Tesla ...

    Benzinga
  43. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  44. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  45. Morning Market Losers

    Benzinga
  46. Benzinga's Top #PreMarket Losers

    Benzinga
  47. Intercept Reports Additional Details About FLINT Clinical Trial ...

    Benzinga
  48. Intercept to Present at the JP Morgan Healthcare Conference on ...

    Benzinga
  49. Market Wrap For January 10: Job Growth Weak, But Unemployment ...

    Benzinga
  50. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing ...

    Benzinga
  51. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; ...

    Benzinga
  52. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
  53. Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss ...

    Benzinga
  54. Bank of America Reiterates on Intercept Pharmaceuticals

    Benzinga
  55. Benzinga's Volume Movers

    Benzinga
  56. Stocks Hitting 52-Week Highs

    Benzinga
  57. Citi Maintains on Intercept Pharmaceuticals

    Benzinga
  58. Stock Futures Trim Early Gains; Oriental Education Leads IBD ...

    IBD
  59. Benzinga's Top #PreMarket Gainers

    Benzinga
  60. Intercept drug hits endpoint

    IBD
  61. Mid-Afternoon Market Update: Markets Moving Sideways Ahead of ...

    Benzinga
  62. Mid-Day Market Update: U.S. Stocks Turn Red; Bed Bath & Beyond ...

    Benzinga
  63. Intercept Pharma Liver-Disease Drug Scores In Trial

    IBD
  64. Benzinga's Volume Movers

    Benzinga
  65. Morning Market Movers

    Benzinga
  66. Benzinga's Top #PreMarket Gainers

    Benzinga
  67. Intercept Pharmaceutical Shares Skyrocket after Oppenheimer's ...

    Benzinga
  68. Intercept Prices 1.5M Share Offering at $62.50/Share

    Benzinga
  69. UPDATE: BMO Capital Markets Raises PT on Intercept Pharmaceuticals ...

    Benzinga
  70. UPDATE: Wedbush Raises PT on Intercept Pharmaceuticals Following ...

    Benzinga
  71. Intercept Pharma Begins Phase 2 NASH Trial of OCA in Japan

    Benzinga
  72. Intercept Pharmaceuticals Completes Enrollment in Phase 3 Primary ...

    Benzinga
  73. UPDATE: BMO Capital Markets Initiates Intercept Pharmaceuticals ...

    Benzinga
  74. Stocks Hitting 52-Week Lows

    Benzinga
  75. Four IPOs Burst Out The Gate

    IBD
  76. Realogy, Shutterstock IPOs, More New Stocks Take Off

    IBD
  77. Realogy, Shutterstock IPOs, More New Stocks Take Off

    IBD
Trading Center